Cite
CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions: One Size Rarely Fits All.
MLA
Moliterno, David J., et al. “CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions: One Size Rarely Fits All.” JAMA: Journal of the American Medical Association, vol. 324, no. 8, Aug. 2020, pp. 747–49. EBSCOhost, https://doi.org/10.1001/jama.2020.13094.
APA
Moliterno, D. J., Smyth, S. S., & Abdel-Latif, A. (2020). CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions: One Size Rarely Fits All. JAMA: Journal of the American Medical Association, 324(8), 747–749. https://doi.org/10.1001/jama.2020.13094
Chicago
Moliterno, David J., Susan S. Smyth, and Ahmed Abdel-Latif. 2020. “CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions: One Size Rarely Fits All.” JAMA: Journal of the American Medical Association 324 (8): 747–49. doi:10.1001/jama.2020.13094.